Latest News
Kromek Shares Gain On Nuclear Detection Contract
Kromek Group (LON: KMK) shares are climbing on Tuesday after the company announced it has been awarded a nuclear detection contract worth a minimum of $960,000. The worldwide supplier of detection technology said approximately $150,000 of the cont
Journeo (JNEO) Shares Rally After Securing First Bus Extension
Advanced information systems and technical services firm Journeo plc (LON: JNEO) announced that it has secured a one-year extension to a framework agreement with First Bus UK. The extension will see the current contract continue to March 2022 and
Invinity Shares Spike As it Upscales Manufacturing Capacity
Invinity Energy (LON: IES) provided an early 2021 trading update on Tuesday, building on its record orders from 2020, resulting in its share price climbing over 10.5%. The company confirmed a 100% increase in stack manufacturing capacity (vs Decem
I3 Energy Shares Rise As Canadian Assets Beat Forecasts
I3 Energy’s (LON: I3E) share price is rising on Tuesday after the company revealed its production volumes in Canada exceeded the forecasted rates of the competent persons reports used for i3's 2020 AIM Re-admission documents by over 1,000 boe/d. T
Hurricane Energy (HUR) Shares Edged 8.4% Higher, Can they Extend the Uptrend?
Shares of Hurricane Energy PLC (LON: HUR) rallied 8.4% higher in an attempt to break above recent highs despite the lack of news releases from the company in the recent past. The oil exploration company’s last major announcement was mid-January wh
Horizonte Minerals Shares Fall After Raising £18m From Placing
Shares of nickel development company Horizonte Minerals (LON: HZM) are sliding on Friday after the company announced the completion of its share placing, which raised £18 million in total. The AIM-listed company announced the fundraise in a statem
Horizonte Minerals (HZM) Shares Are Up Over 35% In 2021, Will They Keep Rising?
Shares of Horizonte Minerals Plc (LON: HZM) are up 35% so far this year, and investors wonder whether the stock will keep rising. The short answer is, yes, the mining company’s stock price is likely to keep rising all things remaining constant, bu
Horizonte Minerals Awarded Construction License
Horizonte Minerals (LON: HZM) announced on Wednesday that it has been awarded the construction licence package to develop the power line for its 100% owned Araguaia Ferronickel Project in Brazil. The package includes the preliminary licence, the c
Heiq Shares Crash 21.9% Despite Releasing an Upbeat Trading Update for FY 2020
Shares of Heiq PLC (LON: HEIQ) crashed 21.9% after the innovative Swiss textiles company released a positive trading update for the financial year ended 31 December 2020. The company said that it expects revenues for its 2020 financial year to bea
Gunsynd Shares Creep Higher After Increasing Low6 Investment
Gunsynd (LON: GUN) shares are rising on Friday after the company said it has increased its investment in Low6, a UK based B2B pool betting platform for franchises. Gunsynd said it has invested approximately £65,000 in Low6, which offers a white-la
Greatland Gold Lodges New Exploration License Application
Greatland Gold (LON: GGP) said on Thursday that it has lodged an application for a new exploration licence in the Paterson region. The Canning exploration licence application comprises 114 km and is located a
Goldstone Resources Granted Environmental Permit, Shares Rally
Goldstone Resources Limited (LON: GRL) shares trading higher on Friday after the company announced that the Ghanaian Environmental Protection Agency has granted the environmental permit for the company’s Homase South Pit within the AKHM project. T
Genedrive Shares Spike 8.2% After Partnering With a US Military Contractor
Shares of British diagnostics company Genedrive PLC (LON: GDR) spiked 8.2% higher after the company signed an agreement with US military contractor Mountain Horse Solutions to distribute its rapid diagnostics products in the country. The molecular
Genedrive Shares Slightly Higher After AHIL Assay Update
Shares of genedrive (LON: GDR) initially spiked higher on Wednesday after the company provided an update on its Antibiotic Induced Hearing Loss assay. Genedrive said they and Inspiration Healthcare Group, the distribution partner for the AIHL assa
Genedrive Shares Rally 30.2% as FOMO Grips Investors After the Latest Partnership
Shares of Genedrive PLC (LON: GDR) rallied 30.2% higher fueled by the fear of missing out (FOMO) as investors caught up on the potential in the company’s latest announcement regarding its partnership with Beckman Coulter. The molecular diagnostics
Genedrive Shares Jump As First 96 SARS-CoV-2 Kits Shipments Sent to the US
Shares of molecular diagnostics company, Genedrive plc (LON: GDR) jumped over 20% on Wednesday after it said the first shipments of its Genedrive 96 SARS-CoV-2 Kits have been made to the United States. The announcement comes following its distribu
Genedrive Shares Gain After Beckman Coulter Partnership Announcement
Near patient molecular diagnostics company, Genedrive PLC (LON: GDR) said on Thursday it has entered into a distribution agreement with Beckman Coulter Life Sciences for its Genedrive 96 SARS-CoV-2 Kit. The agreement will see Beckman Coulter sell
FastForward Innovations Shares Fall After Agreeing To Sell Interest In EMMAC
Shares of FastForward Innovations (LON: FFWD) are down on Wednesday after the company said it has agreed to sell its entire interest in EMMAC Life Sciences as part of Curaleaf's takeover of the company. EMMAC, a cannabis firm, will be acquired by
FastForward Innovations Invests in A$1m in Little Green Pharma
FastForward Innovations (LON: FFWD) said on Friday that it has invested A$1 million (£560,000) in a placing undertaken by Little Green Pharma, an ASX-listed medicinal cannabis business with operations from cultivation and production through to manufa
Faron Pharmaceuticals Shares Climb As COVID-19 Drug Gets Trial Approval
London-listed shares of Faron Pharmaceuticals (LON: FARN) are trading higher on Tuesday after the company said the US Food and Drug Administration (FDA) has approved the phase 2/3 HIBISCUS trial assessing traumakine, Faron’s intravenous IFN beta-1a,